State of Wyoming’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

State of Wyoming’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-193	Closed	-$43K	–	1802
2022 Q3	$43K	Buy	193 +187	+3,117%	+$37.8K	0.02%	1072
2022 Q2	$1K	Buy	6 +1	+20%	+$115	﹤0.01%	1822
2022 Q1	$1K	Buy	5 +1	+25%	+$113	﹤0.01%	1759
2021 Q4	$1K	Hold	4	–	–	﹤0.01%	1836
2021 Q3	$0	Sell	4 -2	-33%	-$231	﹤0.01%	1363
2021 Q2	$1K	Buy	6 +3	+100%	+$351	﹤0.01%	1156
2021 Q1	$0	Buy	+3	New	+$340	﹤0.01%	560

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State of Wyoming's KRTX Position: Q4 2022 in Review

State of Wyoming sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2022, closing a stake of 193 shares — an estimated $43K sold.

State of Wyoming first reported a position in KRTX in Q1 2021 and held it in 7 quarters. The position peaked at $43K in Q3 2022. 248 funds tracked by Wall St. Rank hold KRTX as of Q4 2022.

State of Wyoming reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
State of Wyoming sold 193 Karuna Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $43K.
State of Wyoming first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
State of Wyoming's Karuna Therapeutics, Inc. Common Stock position peaked at $43K in Q3 2022.
248 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2022.

Based on State of Wyoming's 13F filing for Q4 2022, filed 15 Feb 2023.